The U.S. Food and Drug Administration has been grooming selected journalists to give favorable treatment to government findings, and even FDA ad campaigns, by inviting them to elite briefings that other journalists could not attend – or did not know even existed – as long as these special friends in journalism played by a strict set of FDA-friendly rules, as detailed in an exposé by Charles Seife in Scientific American, which confirmed what outsiders had long suspected.
The U.S. Food and Drug Administration has been grooming selected journalists to give favorable treatment to government findings, and even FDA ad campaigns, by inviting them to elite briefings that other journalists could not attend – or did not know even existed – as long as these special friends in journalism played by a strict set of FDA-friendly rules, as detailed in an exposé by Charles Seife in Scientific American, which confirmed what outsiders had long suspected.